✦ LIBER ✦

Structural study of human growth hormone-releasing factor fragment (1–29) by vibrational spectroscopy

✍ Scribed by P Carmona; M Molina; A Lasagabaster

Publisher: Elsevier Science
Year: 1995
Tongue: English
Weight: 586 KB
Volume: 51
Category: Article
ISSN: 1386-1425
DOI: 10.1016/0584-8539(94)01315-8

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Solution structure of human growth hormo

Solution structure of human growth hormone-releasing factor fragment (1–29) by CD: Characteristic conformational change on phospholipid membrane

✍ Shinya Honda; Shinichi Ohashi; Hisayuki Morii; Hatsuho Uedaira 📂 Article 📅 1991 🏛 Wiley (John Wiley & Sons) 🌐 English ⚖ 504 KB

The conformations of synthetic human growth hormone-releasing factor fragment (1-29) in the presence and the absence of 1,2-dimyristoyl-sn-glycero-3-phosphorylglycerol liposome as well as in aqueous 2,2,2-trifluoroethanol solution were investigated by CD spectroscopy. The secondary structure of the

Secondary structure of the human growth

Secondary structure of the human growth hormone releasing factor (GRF 1–29) by two-dimensional 1H-nmr spectroscopy

✍ Y. Theriault; Y. Boulanger; J. K. Saunders 📂 Article 📅 1988 🏛 Wiley (John Wiley & Sons) 🌐 English ⚖ 429 KB 👁 2 views

Stimulation of growth hormone secretion

Stimulation of growth hormone secretion with human growth hormone releasing factors (GRF1–44, GRF1–40, GRF1–29) in normal subjects

✍ Losa, M. ;Schopohl, J. ;Müller, O. A. ;Werder, K. 📂 Article 📅 1984 🏛 Springer-Verlag 🌐 English ⚖ 349 KB

Inhibition of proliferation in human MNN

Inhibition of proliferation in human MNNG/HOS osteosarcoma and SK-ES-1 Ewing sarcoma cell lines in vitro and in vivo by antagonists of growth hormone-releasing hormone : Effects on insulin-like growth factor II

✍ Ryszard Braczkowski; Andrew V. Schally; Artur Plonowski; Jozsef L. Varga; Kate G 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 331 KB 👁 2 views

## Abstract ## BACKGROUND Antagonists of growth hormone‐releasing hormone (GH‐RH) can inhibit the proliferation of various tumors either indirectly through the suppression of the pituitary growth hormone/hepatic insulin‐like growth factor I (__IGF‐I__) axis and the lowering of serum __IGF‐I__ conc